Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor

Journal of Experimental Medicine

Volumn 202, Issue 6, 2005, Pages 853-863

  Kihara, Yasuyuki ^a   Ishii, Satoshi ^a   Kita, Yoshihiro ^a   Toda, Akiko ^a   Shimada, Atsuyoshi ^b   Shimizu, Takao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN G2A; INTERLEUKIN 6; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE SEVERITY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; INCIDENCE; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD; SYMPTOMATOLOGY; T LYMPHOCYTE; TH1 CELL; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SPINAL CORD;

EID: 25144475534     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050660     Document Type: Article

References (59)

1. Steinman, L. 2001. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:762-764.
2. Ermann, J., and C.G. Fathman. 2001. Autoimmune diseases: genes, bugs and failed regulation. Nat. Immunol. 2:759-761.
3. Iglesias, A., J. Bauer, T. Litzenburger, A. Schubart, and C. Linington. 2001. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia. 36:220-234.
4. Pedotti, R., J.J. De Voss, L. Steinman, and S.J. Galli. 2003. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24:479-484.
5. Pedotti, R., J.J. DeVoss, S. Youssef, D. Mitchell, J. Wedemeyer, R. Madanat, H. Garren, P. Fontoura, M. Tsai, S.J. Galli, et al. 2003. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA. 100:1867-1872.
6. Steinman, L. 2003. Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J. Exp. Med. 197:1065-1071.
7. Ishii, S., and T. Shimizu. 2000. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39:41-82.
8. Montrucchio, G., G. Alloatti, and G. Camussi. 2000. Role of plateletactivating factor in cardiovascular pathophysiology. Physiol. Rev. 80:1669-1699.
9. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Toh, K. Ito, T. Miyamoto, and T. Shimizu. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349:342-346.
10. Ishii, S., T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, S. Sunaga, W.H. Cao, K. Kume, Y. Fukuchi, K. Ikuta, et al. 1998. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1779-1788.
11. Hikiji, H., S. Ishii, H. Shindou, T. Takato, and T. Shimizu. 2004. Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. J. Clin. Invest. 114:85-93.
12. Ishii, S., T. Nagase, H. Shindou, H. Takizawa, Y. Ouchi, and T. Shimizu. 2004. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model. J. Immunol. 172:7095-7102.
13. Callea, L., M. Arese, A. Orlandini, C. Bargnani, A. Priori, and F. Bussolino. 1999. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. J. Neuroimmunol. 94:212-221.
14. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500-508.
15. Howat, D.W., N. Chand, P. Braquet, and D.A. Willoughby. 1989. An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. Agents Actions. 27:473-476.
16. Desai, S., and R. Barton. 1990. Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. Agents Actions. 31:43-46.
17. Vela, L., A. Garcia Merino, S. Fernandez-Gallardo, M. Sanchez Crespo, J.J. Lopez Lozano, and C. Saus. 1991. Platelet-activating factor antagonists do not protect against the development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 33:81-86.
18. Dulioust, A., E. Vivier, P. Salem, J. Benveniste, and Y. Thomas. 1988. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4 cell proliferation. J. Immunol. 140:240-245.
19. Rola-Pleszczynski, M., C. Pouliot, S. Turcotte, B. Pignol, P. Braquet, and L. Bouvrette. 1988. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. J. Immunol. 140:3547-3552.
20. Dulioust, A., V. Duprez, C. Pitton, P. Salem, A. Hemar, J. Benveniste, and Y. Thomas. 1990. Immunoregulatory functions of paf-acether. III. Down-regulation of CD4 T cells high-affinity IL-2 receptor expression. J. Immunol. 144:3123-3129.
21. Eugster, H.P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178-2187.
22. Mendel, I., A. Katz, N. Kozak, A. Ben-Nun, and M. Revel. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1727-1737.
23. Okuda, Y., S. Sakoda, C.C. Bernard, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:703-708.
24. Samoilova, E.B., J.L. Horton, B. Hilliard, T.S. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-6486.
25. Okuda, Y., S. Sakoda, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1999. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101:188-196.
26. Okuda, Y., S. Sakoda, Y. Saeki, T. Kishimoto, and T. Yanagihara. 2000. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 105:120-123.
27. Eugster, H.P., K. Frei, F. Winkler, U. Koedel, W. Pfister, H. Lassmann, and A. Fontana. 2001. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur. J. Immunol. 31:2302-2312.
28. Cua, D.J., B. Hutchins, D.M. LaFace, S.A. Stohlman, and R.L. Coffman. 2001. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166:602-608.
29. Fillatreau, S., C.H. Sweenie, M.J. McGeachy, D. Gray, and S.M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950.
30. Gran, B., G.X. Zhang, S. Yu, J. Li, X.H. Chen, E.S. Ventura, M. Kamoun, and A. Rostami. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104-7110.
31. Zhang, G.X., B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170:2153-2160.
32. Zhang, G.X., S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami. 2003. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J. Immunol. 171:4485-4492.
33. Huang, D.R., J. Wang, P. Kivisakk, B.J. Rollins, and R.M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713-726.
34. Pedotti, R., D. Mitchell, J. Wedemeyer, M. Karpuj, D. Chabas, E.M. Hattab, M. Tsai, S.J. Galli, and L. Steinman. 2001. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2:216-222.
35. Lafaille, J.J., F.V. Keere, A.L. Hsu, J.L. Baron, W. Haas, C.S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307-312.
36. Miller, S.D., and E.M. Shevach. 1998. Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview. Res. Immunol. 149:753-759.
37. Ransohoff, R.M., P. Kivisakk, and G. Kidd. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3:569-581.
38. Teuscher, C., M.E. Poynter, H. Offner, A. Zamora, T. Watanabe, P.D. Fillmore, J.F. Zachary, and E.P. Blankenhorn. 2004. Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells. Am. J. Pathol. 164:883-892.
39. Fife, B.T., G.B. Huffnagle, W.A. Kuziel, and W.J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899-905.
40. Izikson, L., R.S. Klein, I.F. Charo, H.L. Weiner, and A.D. Luster. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192:1075-1080.
41. Chao, W., and M.S. Olson. 1993. Platelet-activating factor: receptors and signal transduction. Biochem. J. 292:617-629.
42. van der Laan, L.J., S.R. Ruuls, K.S. Weber, I.J. Lodder, E.A. Dopp, and C.D. Dijkstra. 1996. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 70:145-152.
43. Stoll, G., and S. Jander. 1999. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58:233-247.
44. Slobodov, U., F. Reichert, R. Mirski, and S. Rotshenker. 2001. Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. Exp. Neurol. 167:401-409.
45. Smith, M.E. 2001. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc. Res. Tech. 54:81-94.
46. Buntinx, M., M. Moreels, F. Vandenabeele, I. Lambrichts, J. Raus, P. Steels, P. Stinissen, and M. Ameloot. 2004. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFNgamma and TNF-alpha on apoptosis. J. Neurosci. Res. 76:834-845.
47. Buntinx, M., E. Gielen, P. Van Hummelen, J. Raus, M. Ameloot, P. Steels, and P. Stinissen. 2004. Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res. 76:846-861.
48. Shindou, H., S. Ishii, N. Uozumi, and T. Shimizu. 2000. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271:812-817.
49. Kalyvas, A., and S. David. 2004. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron. 41:323-335.
50. Shindou, H., S. Ishii, M. Yamamoto, K. Takeda, S. Akira, and T. Shimizu. 2005. Priming effect of lipopolysaccharide on acetyl-coenzyme A:lyso-platelet-activating factor acetyltransferase is MyD88 and TRIF independent. J. Immunol. 175:1177-1183.
51. Holland, M.R., M.E. Venable, R.E. Whatley, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott. 1992. Activation of the acetylcoenzyme A:lysoplatelet- activating factor acetyltransferase regulates platelet-activating factor synthesis in human endothelial cells. J. Biol. Chem. 267:22883-22890.
52. Garcia, M.C., C. Garcia, M.A. Gijon, S. Fernandez-Gallardo, F. Mollinedo, and M. Sanchez Crespo. 1991. Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells. Biochem. J. 273:573-578.
53. Kumar, R., S.A. Harvey, M. Kester, D.J. Hanahan, and M.S. Olson. 1988. Production and effects of platelet-activating factor in the rat brain. Biochim. Biophys. Acta. 963:375-383.
54. Park, T.S., E.R. Gonzales, and J.M. Gidday. 1999. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. J. Cereb. Blood Flow Metab. 19:417-424.
55. Marusic, S., M.W. Leach, J.W. Pelker, M.L. Azoitei, N. Uozumi, J. Cui, M.W.H. Shen, C.M. DeClercq, J.S. Miyashiro, B.A. Carito, et al. Cytosolic phospholipase A2α-deficient mice are resistant to experimental autoimmune encephalomyelitis. J. Exp. Med. 202:841-851.
56. Owen, J.S., R.L. Wykle, M.P. Samuel, and M.J. Thomas. 2005. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. J. Lipid Res. 46:373-382.
57. Kita, Y., T. Takahashi, N. Uozumi, and T. Shimizu. 2005. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Biochem. 342:134-143.
58. Kita, Y., T. Takahashi, N. Uozumi, L. Nallan, M.H. Gelb, and T. Shimizu. 2005. Pathway-oriented profiling of lipid mediators in macrophages. Biochem. Biophys. Res. Commun. 330:898-906.
59. Ichinose, M., N. Hara, M. Sawada, and T. Maeno. 1994. A flow cytometric assay reveals an enhancement of phagocytosis by platelet activating factor in murine peritoneal macrophages. Cell. Immunol. 156:508-518.